<DOC>
	<DOC>NCT00985478</DOC>
	<brief_summary>First in man study with single and multiple rising doses with SLV342</brief_summary>
	<brief_title>First in Man Study With SLV342</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Healthy Exclusion Criteria Not healthy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>First in Man</keyword>
	<keyword>SLV342</keyword>
	<keyword>Atherosclerosis</keyword>
</DOC>